Archives of Neuroscience

Published by: Kowsar

Long-Term Prophylaxis of Migraine

Francesco Raudino 1 , *
Author Information
1 Department of Neurology, Valduce Hospital, Como, Italy
Article information
  • Archives of Neuroscience: October 01, 2014, 1 (3); e19083
  • Published Online: October 1, 2014
  • Article Type: Research Article
  • Received: December 21, 2013
  • Revised: December 25, 2013
  • Accepted: December 29, 2013
  • DOI: 10.5812/archneurosci.19083

To Cite: Raudino F. Long-Term Prophylaxis of Migraine, Arch Neurosci. 2014 ; 1(3):e19083. doi: 10.5812/archneurosci.19083.

Abstract
Copyright © 2014, Tehran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gallai V, Sarchielli P. Diagnostic and therapeutic guidelines for migraine. Italian Society for the Study of Headaches (SISC). J Headache Pain. 2001; 2(1)[DOI]
  • 2. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004; 63(12): 2215-24[PubMed]
  • 3. Members of the task, force , Evers S, Afra J, Frese A, Goadsby PJ, Linde M, et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol. 2006; 13(6): 560-72[DOI][PubMed]
  • 4. Pryse-Phillips WE, Dodick DW, Edmeads JG, Gawel MJ, Nelson RF, Purdy RA, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ. 1997; 156(9): 1273-87[PubMed]
  • 5. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 55(6): 754-62[PubMed]
  • 6. Management of migraine. Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension-Type, Clusture and Medication-Overuse Headache. 2007;
  • 7. Headache and facial neuralgia. treatment recommendations. 2010;
  • 8. Graud G, Lantri-Minet M, Lucas C, Valade D. French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther. 26(8): 1305-18[DOI]
  • 9. Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJ, et al. European principles of management of common headache disorders in primary care. J Headache Pain. 2007; 8 Suppl 1-47[DOI][PubMed]
  • 10. Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J. Long-term migraine prevention with topiramate: open-label extension of pivotal trials. Headache. 2006; 46(7): 1151-60[DOI][PubMed]
  • 11. Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, et al. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2007; 6(12): 1054-62[DOI][PubMed]
  • 12. Pascual J, El Berdei Y, Gomez-Sanchez JC. How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate. J Headache Pain. 2007; 8(2): 90-3[DOI][PubMed]
  • 13. Headache Classification Subcommittee of the International Headache S. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 Suppl 1: 9-160[PubMed]
  • 14. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev. 2004; (2)[DOI][PubMed]
  • 15. Diamond S, Kudrow L, Stevens J, Shapiro DB. Long-term study of propranolol in the treatment of migraine. Headache. 1982; 22(6): 268-71[PubMed]
  • 16. Wober C, Wober-Bingol C, Koch G, Wessely P. Long-term results of migraine prophylaxis with flunarizine and beta-blockers. Cephalalgia. 1991; 11(6): 251-6[PubMed]
  • 17. Bono G, Manzoni GC, Martucci N, Baldrati A, Farina S, Cassabgi F, et al. Flunarizine in common migraine: Italian cooperative trial. II. Long-term follow-up. Cephalalgia. 1985; 5 Suppl 2: 155-8[PubMed]
  • 18. Martinez-Lage JM. Flunarizine (Sibelium) in the prophylaxis of migraine. An open, long-term, multicenter trial. Cephalalgia. 1988; 8 Suppl 8: 15-20[PubMed]
  • 19. Colucci D'Amato C, Colucci D'Amato A, Alfano V, Giordano E, Marmo E. Flunarizine in long-term migraine prophylaxis: clinical evidence. J Med. 1990; 21(3-4): 201-7[PubMed]
  • 20. Nuti A, Lucetti C, Pavese N, Dell'Agnello G, Rossi G, Bonuccelli U. Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients. Cephalalgia. 1996; 16(5): 337-40[PubMed]
  • 21. Silberstein SD, Collins SD. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Headache. 1999; 39(9): 633-43[PubMed]
  • 22. Nelles G, Schmitt L, Humbert T, Becker V, Sandow P, Bornhoevd K, et al. Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting. J Headache Pain. 2010; 11(1): 33-44[DOI][PubMed]
  • 23. Steiner TJ, Findley LJ, Yuen AW. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia. 1997; 17(2): 109-12[PubMed]
  • 24. Gupta P, Singh S, Goyal V, Shukla G, Behari M. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). Headache. 2007; 47(3): 402-12[DOI][PubMed]
  • 25. Jackson JL, Shimeall W, Sessums L, De Zee KJ, Becher D, Diemer M, et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010; 341[DOI]
  • 26. Granella F, Cavallini A, Sandrini G, Manzoni GC, Nappi G. Long-term outcome of migraine. Cephalalgia. 1998; 18 Suppl 21: 30-3[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments